Review: the reemergence of brachytherapy as treatment for non-melanoma skin cancer

References

• Rogers HW, Weinstock MA, Feldman SR, et al. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012. JAMA Dermatol. 2015;151:1081–6.
   PubMed Web of Science ®Google Scholar
• van Loo E, Mosterd K, Krekels GA, et al. Surgical excision versus Mohs’ micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up. Eur J Cancer. 2014;50:3011–20.
   PubMed Web of Science ®Google Scholar
• Kauvar AN, Arpey CJ, Hruza G, et al. Consensus for nonmelanoma skin cancer treatment, Part II: squamous cell carcinoma, including a cost analysis of treatment methods. Dermatol Surg. 2015;41:1214–40.
   PubMed Web of Science ®Google Scholar
• Fort M, Guet S, Husheng S, et al. Role of radiation therapy in melanomas: systematic review and best practice in 2016. Crit Rev Oncol Hematol. 2016;99:362–75.
   PubMed Web of Science ®Google Scholar
• Edwards EK. Grenz ray therapy. Int J Dermatol. 1990;29:17–18.
   PubMed Web of Science ®Google Scholar
• Linos E, VanBeek M, Resneck JS Jr. A sudden and concerning increase in the use of electronic brachytherapy for skin cancer. JAMA Dermatol. 2015;151:699–700.
   PubMed Web of Science ®Google Scholar
• Esteya The gentle option for treating skin cancer Elekta: Elekta AB (pub); 2015. Available from: http://www.esteya.com/patients.php-is-esteya-right-for-you. Accessed May 2, 2017.
   Google Scholar
• Kasper ME, Chaudhary AA. Novel treatment options for nonmelanoma skin cancer: focus on electronic brachytherapy. Med Devices (Auckl). 2015;8:493–502.
   PubMedGoogle Scholar
• Ballester-Sanchez R, Pons-Llanas O, Candela-Juan C, et al. Electronic brachytherapy for superficial and nodular basal cell carcinoma: a report of two prospective pilot trials using different doses. J Contemp Brachytherapy 2016;8:48–55.
   PubMed Web of Science ®Google Scholar
• Ballester-Sanchez R, Pons-Llanas O, Candela-Juan C, et al. Efficacy and safety of electronic brachytherapy for superficial and nodular basal cell carcinoma. J Contemp Brachytherapy 2015;7:231–8.
   PubMed Web of Science ®Google Scholar
• Bhatnagar A. Nonmelanoma skin cancer treated with electronic brachytherapy: results at 1 year. Brachytherapy 2013;12:134–40.
   PubMed Web of Science ®Google Scholar
• Doggett S, Willoughby M, Willoughby C, et al. Incorporation of electronic brachytherapy for skin cancer into a community dermatology practice. J Clin Aesthet Dermatol. 2015;8:28–32.
   PubMedGoogle Scholar
• Paravati AJ, Hawkins PG, Martin AN, et al. Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer. Pract Radiat Oncol. 2015;5:e659–64.
   PubMed Web of Science ®Google Scholar
• Skowronek J. Brachytherapy in the treatment of skin cancer: an overview. Postepy Dermatol Alergol. 2015;32:362–7.
   PubMed Web of Science ®Google Scholar
• Alam M, Nanda S, Mittal BB, et al. The use of brachytherapy in the treatment of nonmelanoma skin cancer: a review. J Am Acad Dermatol. 2011;65:377–88.
   PubMed Web of Science ®Google Scholar
• Guix B, Finestres F, Tello J, et al. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds. Int J Radiat Oncol Biol Phys. 2000;47:95–102.
   PubMed Web of Science ®Google Scholar
• Arenas M, Arguis M, Diez-Presa L, et al. Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment. Brachytherapy 2015;14:859–65.
   PubMed Web of Science ®Google Scholar
• Delishaj D, Laliscia C, Manfredi B, et al. Non-melanoma skin cancer treated with high-dose-rate brachytherapy and Valencia applicator in elderly patients: a retrospective case series. J Contemp Brachytherapy 2015;7:437–44.
   PubMed Web of Science ®Google Scholar
• Gauden R, Pracy M, Avery AM, et al. HDR brachytherapy for superficial non-melanoma skin cancers. J Med Imaging Radiat Oncol. 2013;57:212–7.
   PubMed Web of Science ®Google Scholar
• Tormo A, Celada F, Rodriguez S, et al. Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomes. J Contemp Brachytherapy 2014;6:167–72.
   PubMed Web of Science ®Google Scholar
• Delishaj D, Rembielak A, Manfredi B, et al. Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature. J Contemp Brachytherapy 2016;8:533–40.
   PubMed Web of Science ®Google Scholar
• Kohler-Brock A, Prager W, Pohlmann S, et al. [The indications for and results of HDR afterloading therapy in diseases of the skin and mucosa with standardized surface applicators (the Leipzig applicator)]. Strahlenther Onkol. 1999;175:170–4.
   PubMed Web of Science ®Google Scholar
• Somanchi BV, Stanton A, Webb M, et al. Hand function after high dose rate brachytherapy for squamous cell carcinoma of the skin of the hand. Clin Oncol (R Coll Radiol). 2008;20:691–7.
   PubMed Web of Science ®Google Scholar
• Svoboda VH, Kovarik J, Morris F. High dose-rate microselectron molds in the treatment of skin tumors. Int J Radiat Oncol Biol Phys. 1995;31:967–72.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Common Terminology Criteria for Adverse Events v4.0. NCI, NIH, DHHS. May 29, 2009. NIH publication # 09-5410. Available from: https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Accessed December 1, 2016.
   Google Scholar
• Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–6.
   PubMed Web of Science ®Google Scholar
• Garcia-Martinez T, Chan JP, Perez-Calatayud J, et al. Dosimetric characteristics of a new unit for electronic skin brachytherapy. J Contemp Brachytherapy 2014;6:45–53.
   PubMed Web of Science ®Google Scholar
• Nucletron B.V. 510(k) summary of safety and effectiveness information as required by section 21 CFR 807.9 [PDF]. U.S. Food and Drug Administration, 2013. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf13/k132092.pdf. Accessed September 3, 2016.
   Google Scholar
• Cognetta AB, Jr., Wolfe CM, Goldberg DJ, et al. Practice and educational gaps in radiation therapy in dermatology. Dermatol Clin. 2016;34:319–33.
   PubMed Web of Science ®Google Scholar
• Bhatnagar A. Electronic brachytherapy for the treatment of nonmelanoma skin cancer: results up to 4 years. Int J Radiat Oncol Biol Phys. 2014;90:S756.
   PubMed Web of Science ®Google Scholar
• Halem ML, Ratner D, Patel A. Basal cell carcinoma. In: Alam M, ed. Evidence-Based Procedural Dermatology. New York, NY: Springer, 2011. p 33–55.
   Google Scholar
• Mosterd K, Krekels GA, Nieman FH, et al. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years’ follow-up. Lancet Oncol. 2008;9:1149–56.
   PubMed Web of Science ®Google Scholar
• Smeets NW, Krekels GA, Ostertag JU, et al. Surgical excision vs Mohs’ micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 2004;364:1766–72.
   PubMed Web of Science ®Google Scholar
• Association AAoDaA. Position Statement on Electronic Surface Brachytherapy for Basal Cell Carcinoma (BCC) and Squamous Cell Carcinomas (SCC) (Approved by the Board of Directors November 13, 2013; revised March 22, 2014a; revised August 9, 2014), 2014.
   Google Scholar